Dr. Ana Isabel Flores received her undergraduate degree from the School of Pharmacy of the Universidad de Salamanca. She joined the Centro de Biología Molecular Severo Ochoa (CBMSO) and obtained her PhD degree from the School of Chemistry of the Universidad Autónoma de Madrid. She received the Doctoral Thesis Award. She initiated her postdoctoral studies at Case Western Reserve on the identification of genes involved in cell cycle checkpoint control in cancer and cardiovascular diseases. Later, she moved to The Cleveland Clinic Foundation to study the survival signaling pathways in oligodendrocytes to understand the development of Multiple Sclerosis. In 2004, she joined the Hospital Universitario 12 de Octubre as a Research Scientist. Since then, Dr. Flores have created a new research line at the institution, focused on the study of the therapeutic effect of human placental stem cells in several diseases.